/Dr. Fred Apple
New IFCC Task Force on Cardiac Biomarker Guidelines: Impact on Patient Care
New IFCC Task Force on Cardiac Biomarker Guidelines: Impact on Patient Care
24 Jul 2018

Cardiac troponin is a marker of cardiac injury, enabling clinicians to aid in the diagnosis of myocardial infarction. Dr. Fred Apple, Director of Clinical Laboratories at Hennepin County Medical Center, describes how new IFCC recommendations and guidelines — for implementing high-sensitivity cardiac troponin assays — will improve cardiac triage and patient outcomes worldwide.

Other Videos by Dr. Fred Apple

Related Scientists

Related Content